{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:20:47Z","timestamp":1770502847344,"version":"3.49.0"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T00:00:00Z","timestamp":1190937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:p><jats:bold>Objective\u2002<\/jats:bold> To determine the incidence of early adverse effects associated with antidepressant drug use during pregnancy.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Prospective, controlled cohort study.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold> A Drug and Health Information Centre in Milan, Italy.<\/jats:p><jats:p><jats:bold>Population\u2002<\/jats:bold> A total of 200 neonates exposed to antidepressants <jats:italic>in utero <\/jats:italic>and 1200 controls.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Women who took antidepressants during pregnancy and delivered liveborn children between 1995 and 2003 were selected. Each case was matched for maternal age and gravidity to six randomly selected controls (not exposed to teratogenic drugs or drugs known to cause neonatal side effects). Odds ratio was estimated for attributable risks.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> Neonatal adverse events and Special Care Unit admission rate, assessed through an interview with the mothers.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of the 200 neonates exposed to antidepressants <jats:italic>in utero<\/jats:italic>, 14 had adverse events and 3 required Special Care Unit admission. Jaundice (<jats:italic>n <\/jats:italic>= 5), agitation (<jats:italic>n <\/jats:italic>= 3) and respiratory distress (<jats:italic>n <\/jats:italic>= 2) were the most common symptoms. In the control group, 50 newboms had side effects and no statistically significant differences in the prevalence rate compared to the exposed group were found, even after stratification for drugs and pregnancy period of exposure. Only the prematurity rate was significantly higher in exposed compared to non\u2010exposed newborns (OR = 2.31; 95% CI 1.14\u20134.63).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> These results do not support an association between antidepressant exposure and unsafe fetal and neonatal outcomes in newborns. However, a collaborative international multicentre epidemiological monitoring of the use of psychotropic drugs during pregnancy is needed in order to guarantee pregnant women and their children safe and effective treatments, both at brief and long time from exposure.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2007.01518.x","type":"journal-article","created":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T10:03:07Z","timestamp":1197021787000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study"],"prefix":"10.1111","volume":"115","author":[{"given":"S","family":"Maschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Clavenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Campi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Schiavetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bernat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bonati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000183597.31630.db"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211352"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000187302.61812.53"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000150228.61501.e4"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1084"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.02.019"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2006.03.019"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000239581.76793.ae"},{"key":"e_1_2_5_10_2","unstructured":"Glaxo SmithKline Clinical Trial Register.Epidemiology study: updated preliminary report on bupropion and other antidepressants including paroxetine in pregnancy and the occurrence of cardiovascular and major congenital malformation.2005[http:\/\/ctr.gsk.co.uk\/summary\/paroxetine\/epip083part2.pdf]. Accessed 26 August 2007."},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.11.006"},{"key":"e_1_2_5_12_2","unstructured":"US Food and Drug Administration.FDA Medwatch drug alert on Paxil (paroxetine HCl) and generic paroxetine.2005[www.fda.gov\/medwatch\/safety\/2005\/safety05.htm#Paxil3]. Accessed 26 August 2007."},{"key":"e_1_2_5_13_2","unstructured":"Nota informativa importante concordata con le autorit\u00e0 regolatorie europee e l\u2019Agenzia Italiana del Farmaco (AIFA). [www.agenziafarmaco.it\/aifa\/servlet\/wscs_render_attachment_by_id\/tipo_file.pdf?id=111.86882.1140189014765&language=IT&lenient=false]. Accessed 26 August 2007."},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.19.2372"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.11.1129"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.898"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17865-9"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00877-5"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351402"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0214"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2133"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.2.173"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558237"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.12.2055"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06071172"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(199907)14:5<319::AID-HUP99>3.0.CO;2-D"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050664"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.8.609"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066584"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067407"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20099"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.11.1889"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.161.1.22"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.139"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.14.1631"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.5.499"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200612000-00058"},{"key":"e_1_2_5_38_2","volume-title":"NICE Clinical Guideline 45. Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance","author":"National Institute for Health and Clinical Excellence","year":"2007"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2007.01518.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2007.01518.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T16:48:53Z","timestamp":1694537333000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2007.01518.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1471-0528.2007.01518.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2007.01518.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]},"assertion":[{"value":"2007-12-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}